Results 201 to 210 of about 15,382 (226)

Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Expert Opinion on Biological Therapy, 2020
Jong Wook Lee, Austin Kulasekararaj
exaly  

Emerging drugs for the treatment of paroxysmal nocturnal hemoglobinuria

Expert Opinion on Emerging Drugs, 2022
, Flore Sicre De Fontbrune
exaly  

Paroxysmal nocturnal hemoglobinuria

Experimental Hematology, 2002
Anna Lyakisheva, Olga Felda, Arnold Ganser, Reinhold E. Schmidt, Jörg Schubert   +4 more
openaire   +3 more sources

Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction

SAGE Open Medicine, 2023
Saad Syed, Danish Safi, Salah Ud Din Safi   +2 more
exaly  

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.

Journal of Experimental Medicine, 1987
Muller-Eberhard H J, Frank M M, Zalman L S   +2 more
exaly  

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.

Journal of Experimental Medicine, 1983
Robert Schreiber, Muller-Eberhard H J, Schreiber R D   +2 more
exaly  

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Therapeutic Advances in Hematology, 2019
Robert Stern, Nathan Connell
exaly  

Leukemia Arising out of Paroxysmal Nocturnal Hemoglobinuria

Leukemia and Lymphoma, 1999
Edward Medof, James Eshleman, M E Medof   +2 more
exaly  

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Blood, 2008
Peter Hillmen, Robert Brodsky, Antonio Maria Risitano   +2 more
exaly  

Paroxysmal Nocturnal Hemoglobinuria

2016
Farah Jijina, Sonali Sadawarte
openaire   +2 more sources